The exercise period for CLS warrants of series TO 7 begins today

In June 2024, Clinical Laserthermia Systems AB (publ) (“CLS” or the “Company”) carried out a rights issue of shares and warrants

READ MORE

New board member of CLS buys shares in the company and the CEO and EVP Operations increase their shareholdings

Lund, Sweden – Clinical Laserthermia Systems AB (publ) (“CLS” or the “Company”) today announces that the Company’s new Board member Peter

READ MORE

CLS enters subscription undertakings and guarantee commitments for the redemption of warrants of series TO 7 B

Clinical Laserthermia Systems AB (“CLS” or the “Company”) announces that the Company has entered into agreements of subscription undertakings and guarantee

READ MORE

CLS reschedules the publication of the Q3 2024 interim report to an earlier date and invites to a webcast

Lund, Sweden – Clinical Laserthermia Systems AB (publ) (“CLS” or “the Company”) today announces that the Company is bringing forward the

READ MORE